The introduction of systematic genomic testing for patients with non-small cell lung cancer (NSCLC) at Dana-Farber Cancer Institute (DFCI).
T. M. Ortiz
Consultant or Advisory Role - Pfizer (U)
V. A. Joshi
Consultant or Advisory Role - KEW Group
S. Heon
No relevant relationships to disclose
M. Butaney
No relevant relationships to disclose
L. Chen
No relevant relationships to disclose
D. M. Jackman
Consultant or Advisory Role - Foundation Medicine
D. J. Kwiatkowski
No relevant relationships to disclose
N. I. Lindeman
No relevant relationships to disclose
P. A. Janne
Consultant or Advisory Role - Abbott Laboratories; AstraZeneca (U); Boehringer Ingelheim; Genentech; Pfizer (U); Roche
Stock Ownership - GATEKEEPER Pharmaceuticals
Other Remuneration - Genzyme
B. E. Johnson
Stock Ownership - KEW Group
Other Remuneration - Patent on EGFR testing